ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,587, issued on Feb. 18, was assigned to Visterra Inc. (Waltham, Mass.).
"Humanized complement 5A receptor 1 antibodies and methods of use thereof" was invented by Karthik Viswanathan (Waltham, Mass.), Brian Booth (Waltham, Mass.), Boopathy Ramakrishnan (Waltham, Mass.), Andrew Wollacott (Waltham, Mass.), Gregory Babcock (Waltham, Mass.), Zachary Shriver (Waltham, Mass.) and Lauren Olinski (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides, among other things, two different formats of humanized antibodies against human complement component 5a receptor I. The disclosure also provides a method of treating a s...